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Abstract. SARS-CoV accessory protein Orf8b is involved in suppressing interferon-mediated immune 
response of the infected cell and this might lead to supposition that the corresponding protein 2019-nCoV 
Orf8 shares the same role. But the tertiary structures of these proteins are still unknown, and the primary 
structures demonstrate very low homology and different calculating parameters. This time they both are 
affected by stabilizing selection and in natural viral populations do not tend to be deleted. The question 
whether in this case very different proteins could share the same function rises from the present data. 
1 Introduction  
Single-stranded positive-sense RNA viruses of the 
family Coronaviridae are capable to infect amphibians, 
birds and mammals [1]. In particular, they cause such 
infectious human diseases as Severe Acute Respiratory 
Syndrome (SARS), Middle East Respiratory Syndrome 
(MERS) [2-4] and CoVID-19 [5]. Viruses close to 2019-
nCoV also infect pangolin Manis javanica [6-8] and 
bats, particularly Rhinolophus affinis [9,10]. Several 
other human infecting coronaviruses, such as HCoV-
NL63, HCoV229E, HCoV-OC43 and HCoVHKU1 are 
well known [11]. These viruses are quite different, so 
2019-nCoV and SARS-Cov share only near 70% 
genomic identity [12]. The closest animal counterpart of 
2019-nCoV seems to be the bat virus RaTG13 with 96% 
genomic identity [10].   
So-called accessory proteins of coronaviruses in 
many cases are involved in blocking of the interferon-
mediated immune response of the infected cell [13]. 
Among them polymorphic protein Orf8 is present in 
2019-nCoV and SARS-CoV. In the CoViD-19 pathogen 
and early strains of SARS coronavirus it exists in the 
form of a single 121-122 aa protein. In many other 
SARS strains it is splitted for two different proteins 
Orf8a and Orf8b. They still are coded by one mRNA, 
and their coding sequences partially overlap (Fig. 1). 
On some different models it was shown that the 
SARS proteins Orf8b and joint Orf8ab are involved in 
blocking of interferon induction [15]. They interact 
directly with interferon regulatory factor 3 (IRF3) [16] 
leading to its ubiquitination and degradation, that 
prevents the induction of interferon synthesis by its 
activated form. Orf8a this time prevents the fast 
degradation of Orf8b. Besides in one of models it some 
way prevents expression of Orf8b [15], that itself is 
difficult to interpret.  
 
Fig. 1. Open reading frames for the joint protein Orf8ab (or 
simply Orf8) in animal and early human SARS-CoV and 
splitted Orf 8a and Orf8b in the late human-adapted strains. 
The nucleotide sequence absent in the strains with splitted Orf8 
is marked by arrows. Figure is from the work of Keng and Tan 
[14]. 2019-nCoV resembles upper variant, but lacks Orf9b and 
possess Orf10 right of gene N. 
It seems that comparing the primary sequences of the 
coronaviral proteins similar to Orf8b we should achieve 
high homology and the presence of some invariant 
structural features, ensuring its function that is really 
important and supported by stabilizing selection. 
Otherwise, we should see an example of very fast 
evolution, changing whether function or the structural 
base of its performing. 
2 Materials and methods 
Sequences of the proteins Orf8 and Orf8a are from the 
public database of National Institute of Health of USA. 
Information about genomic polymorphisms of 2019-
nCoV is from the database described in the work of von 
Dorp and coauthors [17]. 
For multiple sequence alignment the program Clustal 
Omega was used [18]. The program Protein BLAST [19] 
was used for search and pairwise alignment of similar 
sequences by the chosen query. The standard settings 
were applied. 
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To assess amino acid composition and determine 
theoretical values of computational protein parameters, 
for instance isoelectric point and grand average of 
hydropathicity, the program ProtParam [20] was applied. 
3 Results and discussion 
Among 11 Orf8b protein sequences belonging to SARS-
CoV isolated from humans only 2 polymorphic positions 
were detected. They both are close to C-terminus. That 
are Lys81Asn and Thr83Ile substitutions. They tend to 
coincide and are the minority. In position 81 both 
residues are positively charged, although to varying 
degrees, in position 83 properties of residue change. 
Other positions seem to be monomorphic in such a 
sampling. 
14 sequences of the joint SARS-CoV Orf8 protein all 
were found to be identical. This sample obviously does 
not exhibit all the variation abilities, but it lets achieve 
the sequence to be relatively conserved in human 
samples. 
Joint Orf8 sequences of SARS-like bat coronaviruses 
are divided to three completely different types. The most 
numerous cluster is including 10 closely homologous 
sequences possessed 17 polymorphic positions, 11 of 
them in the N-terminal region, if to call so 84 N-terminal 
residues basing on the length of presumably homologous 
Orf8b.   
Aligning 13 2019-nCoV Orf8 sequences, 2 close bat 
and 2 pangolin ones, 15 polymorphic positions were 
found in 84 aa arbitrary N-terminal region, besides 16 aa 
deletion in one of the pangolin sequences. 
These four groups of protein sequences, aligned and 
roughly evaluated in terms of their variability, were 
aligned to visualize common features of their regions 
presumably corresponding to SARS-CoV Orf8b. The 
most characteristic sequences were selected to show 
them, giving an idea of the overall picture (fig. 2).  
Thus, sequences of joint SARS-CoV and SARS-CoV 
like Orf8 from samples taken from human (hS), civet 
(cS) and bat (bS), of human SARS Orf8b (8b), of 2019-
nCoV and nCoV-like viruses Orf8 from human (hC), bat 
(bC) and pangolin (pC) were included in the multiple 
alignment. 
SARS-CoV Orf8b has strong homology with some of 
SARS-like viruses from bats, weak homology with Orf8 
from 2019-nCoV and related coronaviruses, and very 
little similarity to the joint Orf8 (Orf8ab) from some 
SARS-CoV forms from human and their close relatives 
from bat and civet. With SARS-CoV with joint Orf8 it 
shares essentially different positions then with 2019-
nCoV. The proteins in our sampling share universally 
only two amino acid positions: Cys40 (Cys83 by 
numeration of 2019-nCoV) and Leu56 (Leu98).  
Such a way, Orf8 protein from SARS pathogens are 
absolutely divergent not only by splitting of Orf8 coding 
sequence but also by the history of this sequence. It may 
be closer to 2019-nCoV in the splitted variant and very 
far from it in the joint one. However, in both cases the 
similarities do not seem completely irregular. 
Percentage of identity between Orf8b and parts of 
SARS-CoV and 2019-nCoV Orf8 aligned with it is only 
17% for SARS fused form and 25% for 2019-nCoV 
protein (tab. 1). The most impressing is completely 
different electric charge of both types SARS-CoV and 
2019-nCoV molecules, that mirrors isoelectric point (pI) 
value. The indexes related to hydrophobicity also differ 
strongly. These data do not testify in favor of functional 
homology between SARS-CoV and 2019-nCoV Orf8 
proteins, even to a greater extent than low levels of 
identity. 
It is known that the capabilities of the joint Orf8 and 
the splitted proteins to bind other viral proteins are 
different [21]. Keng and Tan deduce from these data 
some significant conformational rearrangement that 
occurred because of transition from single to splitted 
protein [14]. But then only the data about interactions 
between SARS-CoV proteins were used. Adopting the 
version of functional homology between 2019-nCoV 
Orf8 and its SARS-CoV counterparts, we should turn 
attention to the conclusions of Wong and coauthors, that 
postulate direct interaction between SARS-CoV Orf8b 
and Orf8ab with human IRF3 [15]. So, we might expect 
that their counterpart in 2019-nCoV Orf8 shares this 
function, but too different protein parameters question 
this point. 
The obtained data do not claim to be the final 
solution to this question, but they draw attention to 
significant differences among coronaviruses designated 
as SARS-CoV, as well as to the deep divergence of Orf8 
proteins. In this regard, attention should be paid to the 
independent adaptation of SARS-CoV and 2019-nCoV 
to reproduction in human cells. In the case of 
commonality of their functions, we have an example of 
convergent evolution, which went significantly different 
ways. If the functions have changed, experimental 
studies can help clarify this complex picture. The 
expectation of structural information about the 
considered proteins becomes more intriguing in the 
presented context. 
Table 1. Comparision of identity percentage between SARS-
COV ORF8B (8B), another SARS-COV joint ORF8 (HS, 
designation as on alignment on fig. 2) and 2019-NCOV ORF8 














8b 84 9.45 88.21 -0.029 
hS 
122 (11%) 8.24 96.72 0.218 
84 (17%) 8.55 88.33 0.038 
hC 
121 (17%) 5.42 97.36 0.219 
81 (25%) 5.18 99.75 0.143 
. 
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Fig. 2. Aligned sequences of joint SARS-CoV and SARS-CoV like Orf8 from samples taken from human (hS), civet (cS) and bat 
(bS), of human SARS Orf8b (8b), of 2019-nCoV and nCoV-like viruses Orf8 from human (hC), bat (bC) and pangolin (pC). Amino 
acid residues matching with those of SARS-CoV Orf8b (8b) are marked gray. 
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